Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 7/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.37 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
| ▸ | STAT3 | P40763 | 1/20 | 0.32 |
| ▸ | FNTA | P49354 | 1/20 | 0.32 |
| ▸ | FNTB | P49356 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13841035 | 0.87 | GAA (0.38) | ALOX15CYP3A4LMNAGAA | |
| SCHEMBL7556771 | 0.87 | ALOX15 (0.44) | ALOX15CYP3A4LMNAGAAALDH1A1 | |
| SCHEMBL11132786 | 0.84 | ALOX15 (0.44) | ALOX15CYP3A4LMNAGAAALDH1A1 | |
| SCHEMBL16464536 | 0.83 | GAA (0.35) | ALOX15CYP3A4LMNAGAAALDH1A1 | |
| SCHEMBL28126961 | 0.83 | ALOX15 (0.36) | ALOX15CYP3A4LMNAGAAALDH1A1 | |
| SCHEMBL16464537 | 0.83 | GAA (0.35) | ALOX15CYP3A4LMNAGAAALDH1A1 | |
| SCHEMBL12937360 | 0.82 | GAA (0.50) | LMNAGAAALDH1A1TSHR | |
| SCHEMBL30819261 | 0.82 | ALOX15 (0.35) | ALOX15CYP3A4LMNAALDH1A1HIF1A | |
| SCHEMBL17058709 | 0.79 | ALOX15 (0.44) | ALOX15CYP3A4LMNAALDH1A1HIF1A | |
| SCHEMBL10651515 | 0.79 | ALOX15 (0.44) | ALOX15CYP3A4LMNAGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3867217-B1 | ETHERS AND ESTERS OF TERTIARY ALKANOLS FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2022-12-07 | — | — | EP | disclosed |
| CN-114409537-B | Preparation method of acetate compound and catalyst adopted by preparation method | 山东新和成药业有限公司 | 2022-05-31 | — | — | CN | disclosed |
| CN-114409537-A | Preparation method of acetate compound and catalyst adopted by preparation method | 山东新和成药业有限公司 | 2022-04-29 | — | — | CN | disclosed |
| US-20210388288-A1 | ETHERS AND ESTERS OF TERTIARY ALKANOLS FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2021-12-16 | — | — | US | disclosed |
| CN-112867703-A | Ethers and esters of tertiary alkanols as fragrance chemicals | 巴斯夫欧洲公司 | 2021-05-28 | — | — | CN | disclosed |
| EP-3640233-A1 | ETHERS AND ESTERS OF TERTIARY ALKANOLS FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2020-04-22 | — | — | EP | disclosed |
| US-20180273484-A1 | DIAZIRINES AS PHOTOCAGES WHICH RELEASE MOLECULES CONTAINING DOUBLE BONDS | HENKEL AG & CO. KGAA (DE) | 2018-09-27 | — | — | US | disclosed |
| US-20160106690-A1 | PAIN RELIEF COMPOSITIONS, MANUFACTURE AND USES | API GENESIS, LLC (US) | 2016-04-21 | — | — | US | disclosed |
| US-20160106690-A1 | PAIN RELIEF COMPOSITIONS, MANUFACTURE AND USES | API GENESIS, LLC (US) | 2016-04-21 | — | — | US | disclosed |
| US-8389164-B2 | Nonaqueous electrolytic solution, positive electrode and nonaqueous electrolyte secondary battery | SONY CORPORATION (JP) | 2013-03-05 | — | — | US | disclosed |
| US-8389164-B2 | Nonaqueous electrolytic solution, positive electrode and nonaqueous electrolyte secondary battery | SONY CORPORATION (JP) | 2013-03-05 | — | — | US | disclosed |
| US-8389164-B2 | Nonaqueous electrolytic solution, positive electrode and nonaqueous electrolyte secondary battery | SONY CORPORATION (JP) | 2013-03-05 | — | — | US | disclosed |
| US-20100304224-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION, POSITIVE ELECTRODE AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | SONY CORPORATION (JP) | 2010-12-02 | — | — | US | disclosed |
| US-20100304224-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION, POSITIVE ELECTRODE AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | SONY CORPORATION (JP) | 2010-12-02 | — | — | US | disclosed |
| US-20100304224-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION, POSITIVE ELECTRODE AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | SONY CORPORATION (JP) | 2010-12-02 | — | — | US | disclosed |
| CN-101901933-A | Nonaqueous electrolytic solution, positive pole and rechargeable nonaqueous electrolytic battery | SONY CORP | 2010-12-01 | — | — | CN | disclosed |
| US-5683687-A | LAVENDER ABSOLUTE OR JASMINE ABSOLUTE CONTAINED WITHIN A POLYMER MATRIX | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1997-11-04 | — | — | US | disclosed |
| EP-0131254-B1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED TETRAHYDROFURANES | L. GIVAUDAN & CIE Société Anonyme (CH) | 1988-05-25 | — | — | EP | disclosed |
| EP-0131254-A2 | Process for the preparation of substituted tetrahydrofuranes | L. GIVAUDAN & CIE Société Anonyme (CH) | 1985-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210388288-A1 | ETHERS AND ESTERS OF TERTIARY ALKANOLS FOR USE AS AROMA CHEMICALS | OR51E2, ETV1, ALK | ALOX15 94/4885CYP3A4 29/4885LMNA 1511/4885 |
| US-20160106690-A1 | PAIN RELIEF COMPOSITIONS, MANUFACTURE AND USES | TRPV1, OPRL1, TRPV3 | ALOX15 269/4885CYP3A4 3414/4885LMNA 3920/4885 |
| US-20180273484-A1 | DIAZIRINES AS PHOTOCAGES WHICH RELEASE MOLECULES CONTAINING DOUBLE BONDS | TRPA1, TRPC1, NISCH | ALOX15 1385/4885CYP3A4 2537/4885LMNA 1423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.